Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD)
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RA) have delayed gastric emptying properties; however, the impact on esophagogastroduodenoscopy (EGD) visualization is unknown. Objective: This study examines the impact of GLP-1RA use on EGD visualization and gastric content retention. Methods: This was a retrospective cohort study with matched controls. The primary endpoint was the odds of retained food documented during EGD. Secondary endpoints included incidence of lavage and need for repeat EGD due to poor visualization and were compared using Fisher exact test. Analyses were performed in R Studio. Results: There were 59 patients in the cohort prescribed a GLP-1RA with 118 matched controls. Food retention was documented with 4 patients (6.8%) in the GLP-1RA cohort versus 2 patients (1.7%) in the control group (odds ratio [OR] 4.22 [95% CI 0.87-20.34]). No difference was observed in the need for lavage during EGD or in the need for repeat EGD attributed to poor visualization. Conclusion and Relevance: This study addresses a previously uninvestigated question in clinical practice. GLP-1RA did not significantly increase odds of retained food on EGD. Although a numerical difference was observed, it did not reach statistical difference. No cases required repeat EGD due to poor visualization, and no change to EGD pre-procedure instructions were warranted at the study facility.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies on patients taking GLP-1 RAs have demonstrated increased gastric residue on esophagogastroduodenoscopy [16].”
From Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning (2025) · cites this paper as [16]
In the citing paper
“There is clear evidence that GLP‐1 RAs are associated with delayed gastric emptying in most settings, as shown by: endoscopy [45, 46, 47, 48] (including capsular [49]); sonography [50, 51]; radiolabelled carbon ingestion [52, 53]; paracetamol ingestion [6, 7, 54, 55, 56, 57, 58, 59]; and scintigraphy [29, 60, 61].”
Citations
Cites
Burden of Gastrointestinal Disease in the United States: 2012 Update
Peery, A. F., Dellon, E. S., Lund, J., Crockett, S. D., McGowan, C. E., Bulsiewicz, W. J., Gangarosa, L. M., Thiny, M. T., Stizenberg, K., Morgan, D. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.002 · Cited by 2,015
Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14280 · Cited by 427
Adverse events of upper GI endoscopy
Ben-Menachem, T., Decker, G. A., Early, D. S., Evans, J., Fanelli, R. D., Fisher, D. A., Fisher, L., Fukami, N., Hwang, J. H., Ikenberry, S. O., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.03.252 · Cited by 378
Hjerpsted, J. B., Flint, A., Brooks, A., Axelsen, M. B., Kvist, T., & Blundell, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13120 · Cited by 245
Gastric emptying in patients with insulin-requiring diabetes mellitus.
Keshavarzian, A., Fl, I., & Vaeth, J. (1987) · PubMed · Cited by 201
Nakatani, Y., Maeda, M., Matsumura, M., Shimizu, R., Banba, N., Aso, Y., Yasu, T., & Harasawa, H. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.05.009 · Cited by 126 · cited 2×
“56(8) 922 –926 © The Author(s) 2021 Article reuse guidelines: sagepub.”
Complications of Endoscopy of the Upper Gastrointestinal Tract: A Single-Center Experience
Wolfsen, H. C., Hemminger, L. L., Achem, S. R., Loeb, D. S., Stark, M. E., Bouras, E. P., & DeVault, K. R. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.10.1264 · Cited by 68
Gastric food retention at endoscopy is associated with severity of liver cirrhosis
Snell, D. B., Cohen‐Mekelburg, S., Weg, R., Ghosh, G., Buckholz, A. P., Mehta, A., Ma, X., Christos, P. J., & Jesudian, A. B. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i11.725 · Cited by 10
Research works printed but not linked: 5
- 10.1016/s0016-5107(03)80006. · doi:10.1016/s0016-5107(03)80006
- Keshavarzian Iber FL, 1987, Am J Gastroenterol, 82, 29
- 10.1002/(SICI)1096-9136(199602)13:2<112::AID-DIA37>3.0.CO. · doi:10.1002/(sici)1096-9136(199602)13:2<112::aid-dia37>3.0.co
- 10.1097/00004836-200401000. · doi:10.1097/00004836-200401000
- Fosso Quigley EMM, 2018, Gastroenterol Hepatol (N Y), 14, 140
Cited by
Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia
Sen, S., Potnuru, P. P., Hernandez, N., Goehl, C., Praestholm, C., Sridhar, S., & Nwokolo, O. O. (2024) · JAMA Surgery · doi:10.1001/jamasurg.2024.0111 · Cited by 202
Kobori, T., Onishi, Y., Yoshida, Y., Tahara, T., Kikuchi, T., Kubota, T., Iwamoto, M., Sawada, T., Kobayashi, R., Fujiwara, H., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14005 · Cited by 144
El‐Boghdadly, K., Dhesi, J., Fabb, P., Levy, N., Lobo, D. N., McKechnie, A., Mustafa, O., Newland‐Jones, P., Patel, A., Pournaras, D. J., et al. (2025) · Anaesthesia · doi:10.1111/anae.16541 · Cited by 147
Hiramoto, B., McCarty, T. R., Lodhia, N. A., Jenkins, A., Elnaiem, A., Muftah, M., Flanagan, R., & Chan, W. W. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002820 · Cited by 94
Oprea, A. D., Ostapenko, L. J., Sweitzer, B., Selzer, A., Irizarry-Alvarado, J. M., Hurtado Andrade, M. D., Mendez, C. E., Kelley, K. D., Stewart, E., Fernandez Robles, C. R., et al. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.04.001 · Cited by 104
Metadata
- Authors
- Stark, J. E., Cole, J. L., Ghazarian, R. N., & Klass, M. J.
- Affiliations
- Veterans Health Care System of the Ozarks (US)
- Corresponding author
- Stark, Jennifer E.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2021-11-02
- Volume
- 56
- Issue
- 8
- Pages
- 922-926
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W3209867958
- Cited by
- 77
- References
- 8
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 35 · 2023: 6
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- GLP-1 receptor agonists, upper gastrointestinal endoscopy, gastric emptying, lavage, antidiabetic drugs
- MeSH terms
- Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Retrospective Studies, Endoscopy, Digestive System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.